| Trial ID: | L2512 |
| Source ID: | NCT00923962
|
| Associated Drug: |
Glucagon Like Peptide-1
|
| Title: |
Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Glucagon like peptide-1|DRUG: Adenosine
|
| Outcome Measures: |
Primary: Coronary blood flow, 10 minutes after I.A. GLP-1|Coronary metabolite uptake, 10 minutes after I.A. GLP-1 |
|
| Sponsor/Collaborators: |
Sponsor: University Hospital, Gentofte, Copenhagen | Collaborators: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
35
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
|
| Start Date: |
2009-06
|
| Completion Date: |
2012-01
|
| Results First Posted: |
|
| Last Update Posted: |
2012-09-18
|
| Locations: |
University Hospital Gentofte, Department of Cardiology, Gentofte, 2900, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00923962
|
